logo
  

Vanda : Interim Study Shows Tradipitant Accelerates Improvement In Patients With COVID-19 Pneumonia

Vanda Pharmaceuticals Inc. (VNDA) said the interim analysis of the ODYSSEY study showed that hospitalized patients with COVID-19 pneumonia improved sooner when treated with tradipitant as compared to placebo.

In Tuesday pre-market trade, VNDA was trading at $13.37 up $1.72 or 14.76 percent.

The interim analysis of the ODYSSEY study showed that a 14 day tradipitant treatment accelerated clinical improvement by day 7.

At day 28 of the study, tradipitant showed a numerical benefit over placebo with an earlier median time to recovery.

The finding was based on a preliminary analysis of the first 60 patients enrolled in the ODYSSEY study of tradipitant in COVID-19 pneumonia.

Vanda said it looks forward to collaborating with U.S. government agencies and hospitals across the country to confirm the findings expediently. If those results are confirmed, tradipitant could become part of the standard of care, either alone or in combination with antivirals, for patients with COVID-19 pneumonia.

ODYSSEY is an ongoing Phase III double-blind placebo-controlled trial investigating the efficacy and safety of tradipitant, a neurokinin-1 receptor (NK-1R) antagonist, in the treatment of neurogenic inflammation of the lung secondary to SARS-CoV-2 (COVID-19) infection, which was initiated in April 2020.

The study is expected to enroll 300 patients, and as of July 15, 2020, 60 patients had enrolled and completed the study.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement. The U.S. Food and Drug Administration said it has taken steps to make available millions of cans of additional infant and specialty formula to U.S. consumers in the coming months. Under the agency's recent increased flexibilities, British nutrition products maker Kendal Nutricare will send about 2 million cans of infant formula under the Kendamil brand initially to U.S. beginning in June. Video streaming giant Netflix Inc. announced the availability of a variety of mobile games. Players can download the games directly from the Netflix mobile app. The new games include Dragon Up (East Side Games), Moonlighter (11 Bit Studios), Townsmen - A Kingdom Rebuilt (HandyGames), and Exploding Kittens - The Game (Exploding Kittens Digital).
Follow RTT